Literature DB >> 33573309

The Perioperatively Altered Neutrophil-to-Lymphocyte Ratio Associates with Impaired DNA Damage Response in Liver Transplantation Recipients with Hepatocellular Carcinoma.

Kuang-Den Chen1,2, Chien-Ning Hsu3, Yi-Ju Wu1, Chi-Hsiang Chu4, Kuang-Tzu Huang1,2, Ming-Chao Tsai5, King-Wah Chiu5, Ben-Chung Cheng6, Chien-Hua Chiu6, Chao-Long Chen1,2, Chih-Che Lin1.   

Abstract

Increasing evidence has suggested that elevated systemic inflammation with a high neutrophil-lymphocyte ratio (NLR) is associated with poor prognosis after liver transplantation (LT). The ongoing molecular events involved in poor survival remain unclear. This retrospective study evaluated LT recipients whose data was collected at Kaohsiung Chang Gung Memorial Hospital between 2005 and 2014. Clinical records of 347 patients with hepatocellular carcinoma from seven days before LT to 30 days after LT illustrated that longitudinal values of lymphocytes, RBC, and hemoglobin were persistently low in patients with peritransplant high NLR (PTH-NLR, pre-LT ≥ 4 and post-LT ≥ 5), which indicated a significantly worse survival rate in association with increased RDW-CV and pancytopenia when compared to other patients (p = 0.008). We further found that PTH-NLR patients had decreased DNA damage response (DDR) genes and detoxifying enzymes of ADH and ALDH families, and increased mitochondrial stress response genes in their liver tissues. Reduced lineage markers of liver progenitor cells were also observed in PTH-NLR patients signifying the presence of unresolved impairments after LT. Our results demonstrate the association between hematopoietic deficiencies and lack of protection against DDR with PTH-NLR in LDLT recipients with HCC and may imply abnormal hematological and organismal defects in those patients.

Entities:  

Keywords:  DNA damage response; alcohol dehydrogenase; hepatocellular carcinoma; liver transplantation; lymphopenia; neutrophil-to-lymphocyte ratio

Year:  2021        PMID: 33573309      PMCID: PMC7912615          DOI: 10.3390/diagnostics11020209

Source DB:  PubMed          Journal:  Diagnostics (Basel)        ISSN: 2075-4418


  31 in total

1.  Increased autophagy sustains the survival and pro-tumourigenic effects of neutrophils in human hepatocellular carcinoma.

Authors:  Xue-Feng Li; Dong-Ping Chen; Fang-Zhu Ouyang; Min-Min Chen; Yan Wu; Dong-Ming Kuang; Limin Zheng
Journal:  J Hepatol       Date:  2014-08-23       Impact factor: 25.083

2.  Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival.

Authors:  F Y Yao; L Ferrell; N M Bass; J J Watson; P Bacchetti; A Venook; N L Ascher; J P Roberts
Journal:  Hepatology       Date:  2001-06       Impact factor: 17.425

3.  Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study.

Authors:  Alessandro Vitale; Rafael Ramirez Morales; Giacomo Zanus; Fabio Farinati; Patrizia Burra; Paolo Angeli; Anna Chiara Frigo; Paolo Del Poggio; Gianludovico Rapaccini; Maria Anna Di Nolfo; Luisa Benvegnù; Marco Zoli; Franco Borzio; Edoardo Giovanni Giannini; Eugenio Caturelli; Maria Chiaramonte; Franco Trevisani; Umberto Cillo
Journal:  Lancet Oncol       Date:  2011-06-16       Impact factor: 41.316

Review 4.  A model to predict survival in patients with end-stage liver disease.

Authors:  P S Kamath; R H Wiesner; M Malinchoc; W Kremers; T M Therneau; C L Kosberg; G D'Amico; E R Dickson; W R Kim
Journal:  Hepatology       Date:  2001-02       Impact factor: 17.425

5.  Heritable and cancer risks of exposures to anticancer drugs: inter-species comparisons of covalent deoxyribonucleic acid-binding agents.

Authors:  E W Vogel; A Barbin; M J Nivard; H F Stack; M D Waters; P H Lohman
Journal:  Mutat Res       Date:  1998-05-25       Impact factor: 2.433

6.  Neutrophil-lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment.

Authors:  Takashi Motomura; Ken Shirabe; Yohei Mano; Jun Muto; Takeo Toshima; Yuichiro Umemoto; Takasuke Fukuhara; Hideaki Uchiyama; Toru Ikegami; Tomoharu Yoshizumi; Yuji Soejima; Yoshihiko Maehara
Journal:  J Hepatol       Date:  2012-08-25       Impact factor: 25.083

7.  Inflammatory markers as selection criteria of hepatocellular carcinoma in living-donor liver transplantation.

Authors:  Gun Hyung Na; Dong Goo Kim; Jae Hyun Han; Eun Young Kim; Soo Ho Lee; Tae Ho Hong; Young Kyoung You
Journal:  World J Gastroenterol       Date:  2014-06-07       Impact factor: 5.742

8.  Alcohol and endogenous aldehydes damage chromosomes and mutate stem cells.

Authors:  Juan I Garaycoechea; Gerry P Crossan; Frédéric Langevin; Lee Mulderrig; Sandra Louzada; Fentang Yang; Guillaume Guilbaud; Naomi Park; Sophie Roerink; Serena Nik-Zainal; Michael R Stratton; Ketan J Patel
Journal:  Nature       Date:  2018-01-03       Impact factor: 69.504

9.  Genotoxic consequences of endogenous aldehydes on mouse haematopoietic stem cell function.

Authors:  Juan I Garaycoechea; Gerry P Crossan; Frederic Langevin; Maria Daly; Mark J Arends; Ketan J Patel
Journal:  Nature       Date:  2012-08-26       Impact factor: 49.962

10.  Endogenous Formaldehyde Is a Hematopoietic Stem Cell Genotoxin and Metabolic Carcinogen.

Authors:  Lucas B Pontel; Ivan V Rosado; Guillermo Burgos-Barragan; Juan I Garaycoechea; Rui Yu; Mark J Arends; Gayathri Chandrasekaran; Verena Broecker; Wei Wei; Limin Liu; James A Swenberg; Gerry P Crossan; Ketan J Patel
Journal:  Mol Cell       Date:  2015-09-24       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.